BioSpace News Archive

Neovasc Inc. today announced that its Tiara™ (“Tiara”) transcatheter mitral valve replacement device was featured in a “Live Case” broadcast at the 32nd Annual European Association for Cardio-Thoracic Surgery Meeting (“EACTS 2018"), held October 18-20 in Milan, Italy.

Quanterix’ technology to be used in multiplex diagnostic test for cervical disease detection

Free Telephone Counseling Service for People with Lupus Helps Volunteers as Well as Callers

Study findings show a growing trend among surgeons to shift to a less invasive operation, with fewer risks for thyroid cancer patients

Simulations Plus, Inc. today announced that its board of directors has declared its next ongoing quarterly cash dividend of $0.06 per share of the Company’s common stock.

Chardan announced that the firm is acting as lead manager in the follow-on offering for Krystal Biotech, Inc. (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases. The underwritten public offering is valued at $60 million of Krystal Biotech’s common stock.

Proteostasis Therapeutics, Inc. announced today that it intends to offer and sell, subject to market and other conditions, 9,000,000 shares of its common stock in an underwritten public offering.

AtriCure, Inc. today announced that it will be participating in upcoming investor conferences.

Endologix, Inc. today announced that it will report financial results for the third quarter of fiscal year 2018 after the market close on Thursday, November 1, 2018.

CCA Industries, Inc. (NYSE AMERICAN: “CAW”) announced today its results for the third quarter and nine months ended August 31, 2018, which can be found in the table below